{"id":"W4408981570","doi":"10.1016/s1556-0864(25)00489-7","title":"297MO: Patterns of disease progression with durvalumab (D) after concurrent chemoradiotherapy (cCRT) in limited-stage small-cell lung cancer (LS-SCLC): Results from ADRIATIC","year":2025,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Durvalumab; Medicine; Oncology; Stage (stratigraphy); Chemoradiotherapy; Internal medicine; Disease; Cancer; Lung cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006149309,0.0002062533,0.0003100699,0.0006202736,0.0002005111,0.0004625767,0.0002926686,0.0002390827,0.001299049],"category_scores_gemma":[0.001017367,0.0001019748,0.0005054561,0.0006087262,0.0001468452,0.0003903457,0.0002261461,0.0002425365,0.0002793984],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004221403,"about_ca_system_score_gemma":0.0002851651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005084179,"about_ca_topic_score_gemma":0.006964007,"domain_scores_codex":[0.9996698,0.0001020518,0.00003705783,0.0000751419,0.00006533044,0.0000507039],"domain_scores_gemma":[0.9995402,0.0001029341,0.0001675665,0.00004754491,0.00006017644,0.00008158311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02534832,0.0007775559,0.9240904,0.000105953,0.0004861064,0.000117606,0.0001522122,0.0001922725,0.004964501,0.00003375902,0.0003441763,0.04338713],"study_design_scores_gemma":[0.0004477515,0.003257629,0.993575,0.00001089996,0.0003018696,0.0001968968,0.00008522292,0.0002414211,0.001014389,0.00001402424,0.0008473158,0.000007482646],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984151,0.0005599402,0.00002664163,0.00001357838,0.000004090503,0.00001661234,0.0004879071,0.000003783357,0.0004723387],"genre_scores_gemma":[0.998252,0.0002399711,0.00007562448,0.0000204881,0.000007595743,0.00001288812,0.0009574064,0.000002292764,0.000431767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005084179,"threshold_uncertainty_score":0.01010919,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02263174789021557,"score_gpt":0.4437401101460588,"score_spread":0.4211083622558432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}